MAC
51
3
TRIP
60
3
ADSK
61
5
SEE
34
4
BWA
53
3
DIS
75
3
CHD
32
-3
MHK
48
-5
LNC
49
6
BA
52
3
AIV
50
3
INTU
67
2
GT
49
3
IBM
57
3
EXPD
32
3
TJX
53
3
ZTS
31
2
SRE
59
3
LEG
55
-2
STX
69
3
MAC
51
3
TRIP
60
3
ADSK
61
5
SEE
34
4
BWA
53
3
DIS
75
3
CHD
32
-3
MHK
48
-5
LNC
49
6
BA
52
3
AIV
50
3
INTU
67
2
GT
49
3
IBM
57
3
EXPD
32
3
TJX
53
3
ZTS
31
2
SRE
59
3
LEG
55
-2
STX
69
3
Financhill
Back

Bio-Rad Laboratories 10K Form

Sell
38

BIO
Bio-Rad Laboratories

Last Price:
$236.24
Seasonality Move:
2.45%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BIO News And Ratings

See the #1 stock for the next 7 days that we like better than BIO

BIO Financial Statistics

Sales & Book Value

Annual Sales: $2.6B
Cash Flow: $95.5M
Price / Cash Flow: 19.99
Annual Sales: $241.72
Price / Book: 0.96

Profitability

EPS (TTM): -76.20000
Net Income (TTM): $-2.2B
Gross Margin: $1.4B
Return on Equity: -29.59%
Return on Assets: -20.89%

Bio-Rad Laboratories Earnings Forecast

Key Bio-Rad Laboratories Financial Ratios

  • The Gross Profit Margin over the past 41 years for BIO is 53.73%.
  • The Selling, General & Administrative Expenses for BIO have been equal to 31.72% of Gross Profit Margin.
  • The Research & Development expenses have been 11.53% of Revenue.
  • The Net Earning history of BIO is -71.86% of Total Revenues.
  • Per Share Earnings over the last 41 years have been positive in 27 years.

Bio-Rad Laboratories Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: BIO
CUSIP: 090572
Website: bio-rad.com

Debt

Debt-to-Equity Ratio: 0.18
Current Ratio: 5.99
Quick Ratio: 4.12

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 24.79

BIO Technical Analysis vs Fundamental Analysis

Sell
38
Bio-Rad Laboratories (BIO) is a Sell

Is Bio-Rad Laboratories a Buy or a Sell?